Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
a nurse administered only the diluent portion of Shingrix to a patient; a nurse administered only the diluent portion of Shingrix to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 15-JAN-2026, the patient received the 1st dose of Shingrix. On 15-JAN-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: a nurse administered only the diluent portion of Shingrix to a patient) and inappropriate dose of vaccine administered (Verbatim: a nurse administered only the diluent portion of Shingrix to a patient). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 15-JAN-2026 The patient and vaccine details were requested but not provided, as the pharmacist was not the healthcare provider who administered the dose. The reporter stated that they were almost certain that the incorrect dose administered on the day of reporting. The batch number was not provided upon follow up with the reporter.